Driver mutations in non-ABL1 genes, especially RUNX1, are commonly detected in blast phase CML, (BP-CML) [6–10], where there is a strong association between mutational profile and blast phenotype [8]. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.